<DOC>
	<DOC>NCT02832271</DOC>
	<brief_summary>The purpose of the study is to evaluate the efficacy and safety of green tea in endometriosis.</brief_summary>
	<brief_title>Green Tea for Endometriosis</brief_title>
	<detailed_description>Women with endometrioma will be randomised into either the experimental group or the placebo comparator group in a 1:1 ratio. The subjects will be given SUNPHENON EGCg or placebo for 3 months prior to their planned surgery.</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<criteria>Complaints of pelvic pain, dysmenorrhoea and/or dyspareunia â‰¥ 6 months; and Verbal pain rating scale &gt; 4/10 and visual analogue pain scale &gt; 4cm; and Ultrasound confirmed endometrioma; and Planned surgery treatment within 46 months Age &lt; 20 years beyond or &gt;40 year behind the active reproductive age; or BMI &lt;18.5 kg/m2 as underweight or &gt;25 kg/m2 as overweight; or Chronic pelvic pain or low back pain due to other medical conditions, e.g. urological disorders and orthopaedic disorders; or Secondary dysmenorrhoea due to gynaecological conditions other than endometriosis, e.g. pelvic inflammatory diseases, genitourinary infections, gynaecological tumours, etc.; or Primary dysmenorrhoea without any underlying disease identified; or Ultrasound suggested haemorrhagic ovarian cyst, ovarian dermoid cyst, cystic neoplasm, tuboovarian abscess or other ovarian pathologies; or Chronic medical conditions under longterm medications; or Endometriosis under active medication in past 1 month; or History of herbal medicine intake in past 1 month</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>